Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

67
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
67
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

333
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pharmacological treatment of obstructive sleep apnea syndrome].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Features of disorders of the gut microbiota in patients with urolithiasis, depending on the severity of symptoms of intestinal indigestion and indicators obtained in laboratory and instrumental assessment].

Terapevticheskii arkhiv·2026
Same author

[Morning headaches in patients with obstructive sleep apnea syndrome: Pathogenesis, differential diagnosis, and treatment].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Modern view on the effectiveness of surgical methods for treating obstructive sleep apnea syndrome].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2024
Same author

[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2023
Same author

[Cervicogenic vertigo].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2022

Related Experiment Video

Updated: Aug 12, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.7K

[Gut microbiota in patients with relapsing-remitting multiple sclerosis].

M V Tardov1, Sh Talapbek1, N V Sturov1

  • 1Peoples' Friendship University of Russia, Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|January 31, 2023
PubMed
Summary

The gut microbiome influences the gut-brain axis, impacting nervous system regulation. Understanding this connection may offer new therapeutic strategies for neurodegenerative diseases like multiple sclerosis.

Keywords:
bacteriomemicrobiotamycobiomerelapsing-remitting multiple sclerosisvirom

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Related Experiment Videos

Last Updated: Aug 12, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.7K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.0K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Area of Science:

  • Microbiology
  • Neuroscience
  • Gastroenterology

Background:

  • The human body hosts a vast array of microorganisms, collectively known as the microbiota, which play crucial roles in health and disease.
  • The intestinal microbiota, encompassing bacteria, fungi, and viruses, is vital for digestion, vitamin synthesis, and maintaining the gut-brain axis.
  • The gut-brain axis, a bidirectional communication network between the gut microbiota and the central nervous system, is a key area of research for understanding systemic health and neurological disorders.

Approach:

  • This review synthesizes current scientific understanding of the gut microbiota's role in human health.
  • It examines the composition of the bacteriome, mycobiome, and virome within the context of the gut-brain axis.
  • The article specifically focuses on recent findings related to microbiota alterations in patients with relapsing-remitting multiple sclerosis.

Key Points:

  • The intestinal microbiota significantly influences the gut-brain axis, affecting neuroendocrine pathways and central nervous system function.
  • Alterations in gut microbial composition are increasingly implicated in the pathology of neurological conditions.
  • Targeting the gut microbiota presents a potential therapeutic avenue for managing diseases such as neurodegenerative and demyelinating disorders.

Conclusions:

  • The gut-brain axis is a critical interface linking microbial communities to neurological health.
  • Further research into the gut microbiota's composition and function in diseases like multiple sclerosis is warranted.
  • Microbiota-targeted interventions may offer novel adjunctive therapies for neurological conditions.